![Elaine Jones](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Elaine Jones
Net worth: 329 747 $ as of 2025-12-30
Profile
Elaine V.
Jones currently works at HBM Healthcare Investments AG, as Director from 2021, Novartis Venture, as Director, Autifony Therapeutics Ltd., as Non-Executive Director, and various other companies.
Dr. Jones also formerly worked at Gritstone bio, Inc., as Chairman from 2020 to 2025, Mersana Therapeutics, Inc., as Independent Director from 2015 to 2018, Flexion Therapeutics, Inc., as Independent Director from 2009 to 2014, and various other companies.
Dr. Jones received her undergraduate degree from Juniata College and doctorate degree from the University of Pittsburgh School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-03-30 | 1,075 ( 0.02% ) | 307 842 $ | 2025-12-30 | |
| 2025-06-10 | 5,142 ( 0% ) | 21 905 $ | 2025-12-30 | |
NEXTCURE, INC. -.--% | 2025-06-19 | 0 ( -.--% ) | - $ | 2025-12-30 |
Elaine Jones active positions
| Companies | Position | Start |
|---|---|---|
| NEXTCURE, INC. | Director/Board Member | 2015-11-30 |
| CYTOMX THERAPEUTICS, INC. | Director/Board Member | 2019-04-30 |
| HBM HEALTHCARE INVESTMENTS AG | Director/Board Member | 2021-06-17 |
| ATACAMA RESOURCES INTERNATIONAL, INC. | Director/Board Member | - |
Mironid Ltd.
 Mironid Ltd. Develops proprietary drug candidate molecules | Director/Board Member | - |
Myeloid Therapeutics, Inc.
 Myeloid Therapeutics, Inc. Develops therapeutic drugs to focus on immuno-oncology cancer | Director/Board Member | 2021-03-30 |
STORM Therapeutics Ltd.
 STORM Therapeutics Ltd. Develops cancer drug | Director/Board Member | - |
Jnana Therapeutics, Inc.
 Jnana Therapeutics, Inc. Operates as a chemo proteomics platform to develop small molecule medicines | Director/Board Member | - |
Nimbus Apollo, Inc.
 Nimbus Apollo, Inc. Provides drug discovery research services | Director/Board Member | - |
| ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Former positions of Elaine Jones
| Companies | Position | End |
|---|---|---|
| ░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Elaine Jones
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 38 |
|---|---|
Mersana Therapeutics, Inc.
 Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC Provides drug discovery research services | |
NuoDB, Inc.
 NuoDB, Inc. Develops cloud-native distributed SQL database | |
Atacama Resources International, Inc.
 Atacama Resources International, Inc. Engages in exploration of metal ores | |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Finance |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
HBM Healthcare Investments AG
 HBM Healthcare Investments AG Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Miscellaneous |
Targacept, Inc.
 Targacept, Inc. Pharmaceuticals: OtherHealth Technology Discovers and develops nicotinic acetylcholine receptor based therapies | Health Technology |
Juniata College
 Juniata College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pfizer Venture Investments LLC
 Pfizer Venture Investments LLC Investment ManagersFinance Pfizer Ventures Investments invests in companies located across the globe primarily in the United States. The firm focuses on therapeutics platforms tools, and technologies sector. It participates in spinoff and all stages possible with a strong focus on early stage transactions with an investment size of USD 20 million. The firm acquires minority ownership positions and takes board seats where appropriate. It also acts as lead investor. | Finance |
EuclidSR Partners
 EuclidSR Partners Investment ManagersFinance EuclidSR Partners seeks investment opportunities located in the US. The firm target companies operating in the fields of information technology, Convergence, Life sciences. The firm provides financing for early stage capital requirements. | Finance |
Acurian, Inc.
 Acurian, Inc. Medical/Nursing ServicesHealth Services Provides clinical trial patient recruitment and retention solutions for the life sciences industry | Health Services |
Ben Franklin Technology Partners /Ventures/
 Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Tech Partners invests in companies located in the US. The firm focuses on IT, life sciences and physical sciences. It participates in seed and early-stage capital requirements. | Finance |
Aquinox Pharmaceuticals, Inc.
 Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in identification and development of therapeutics for inflammatory diseases and cancer | Health Technology |
Merus NV
 Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Mirna Therapeutics, Inc.
 Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in the development of micro ribonucleic acid based oncology therapeutics | Commercial Services |
NeuroTherapeutics Pharma, Inc.
 NeuroTherapeutics Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical and therapeutic drugs for central nervous system disorders | Health Technology |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Second Genome, Inc.
 Second Genome, Inc. BiotechnologyHealth Technology Develops microbiome-based therapeutic products | Health Technology |
Autifony Therapeutics Ltd.
 Autifony Therapeutics Ltd. Discovers and develops new pharmaceutical treatments treat hearing disorders | |
MISSION Therapeutics Ltd.
 MISSION Therapeutics Ltd. Develops small molecule drugs targeting enzymes involved in cancer and other diseases | |
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. Discovers and develops translation regulators | |
University of Pittsburgh School of Medicine
 University of Pittsburgh School of Medicine Functions as a College/University | |
Quartet Medicine, Inc.
 Quartet Medicine, Inc. Develops treatments for chronic pain and inflammation | |
CytomX Therapeutics, Inc.
 CytomX Therapeutics, Inc. Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | |
Blade Therapeutics, Inc.
 Blade Therapeutics, Inc. Operates as a biopharmaceutical company that focuses on developing treatments for fibrotic and neurodegenerative diseases | |
Gritstone bio, Inc.
 Gritstone bio, Inc. Develops vaccines for cancer for potent and durable immune responses | |
NextCure, Inc.
 NextCure, Inc. Operates as a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases | |
Nimbus Apollo, Inc.
Nimbus Apollo, Inc. Provides drug discovery research services | |
Mironid Ltd.
Mironid Ltd. Develops proprietary drug candidate molecules | |
STORM Therapeutics Ltd.
STORM Therapeutics Ltd. Develops cancer drug | |
Pfizer Ventures LLC
 Pfizer Ventures LLC Provides investment services | |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. Operates as a biotechnology company that develops medicines for health problems | |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. Operates as a chemo proteomics platform to develop small molecule medicines | |
SmithKline Beecham Pharmaceuticals Co.
 SmithKline Beecham Pharmaceuticals Co. Manufactures drugs and vaccines | |
Myeloid Therapeutics, Inc.
Myeloid Therapeutics, Inc. Develops therapeutic drugs to focus on immuno-oncology cancer | |
Ibere Pharmaceuticals
 Ibere Pharmaceuticals Operates as a blank check company |
- Stock Market
- Insiders
- Elaine Jones
